Document
PGR2017-00022, No. 1055 Exhibit - Harden 1055 (P.T.A.B. May. 8, 2017)
Cite Document
PGR2017-00022, No. 1055 Exhibit - Harden 1055 (P.T.A.B. May. 8, 2017)
+ More Snippets
Document
PGR2017-00022, No. 1044 Exhibit - Testim Drug Label (P.T.A.B. May. 8, 2017)
Cite Document
PGR2017-00022, No. 1044 Exhibit - Testim Drug Label (P.T.A.B. May. 8, 2017)
+ More Snippets
Document
PGR2017-00022, No. 1019 Exhibit - Adami (P.T.A.B. May. 8, 2017)
Cite Document
PGR2017-00022, No. 1019 Exhibit - Adami (P.T.A.B. May. 8, 2017)
+ More Snippets
Document
PGR2017-00022, No. 1063 Exhibit - Chapter 3 Pharmacokinetics (P.T.A.B. May. 8, 2017)
Cite Document
PGR2017-00022, No. 1063 Exhibit - Chapter 3 Pharmacokinetics (P.T.A.B. May. 8, 2017)
+ More Snippets
Document
PGR2017-00022, No. 1084 Exhibit - Declaration of David Brayden, PhD (P.T.A.B. May. 3, 2018)
Cite Document
PGR2017-00022, No. 1084 Exhibit - Declaration of David Brayden, PhD (P.T.A.B. May. 3, 2018)
+ More Snippets
Document
PGR2017-00022, No. 1079 Exhibit - Hanna (P.T.A.B. May. 3, 2018)
Cite Document
PGR2017-00022, No. 1079 Exhibit - Hanna (P.T.A.B. May. 3, 2018)
+ More Snippets
Document
PGR2017-00022, No. 1015 Exhibit - Wardley (P.T.A.B. May. 8, 2017)
Cite Document
PGR2017-00022, No. 1015 Exhibit - Wardley (P.T.A.B. May. 8, 2017)
+ More Snippets
Document
PGR2017-00022, No. 1062 Exhibit - Handbook of Pharm Excipients (P.T.A.B. May. 8, 2017)
Cite Document
PGR2017-00022, No. 1062 Exhibit - Handbook of Pharm Excipients (P.T.A.B. May. 8, 2017)
+ More Snippets
Document
PGR2017-00022, No. 1041 Exhibit - US Patent No 9,216,168 (P.T.A.B. May. 8, 2017)
Cite Document
PGR2017-00022, No. 1041 Exhibit - US Patent No 9,216,168 (P.T.A.B. May. 8, 2017)
+ More Snippets
Document
PGR2017-00022, No. 1027 Exhibit - Intl Patent App Pub No WO2011014781 (P.T.A.B. May. 8, 2017)
Cite Document
PGR2017-00022, No. 1027 Exhibit - Intl Patent App Pub No WO2011014781 (P.T.A.B. May. 8, 2017)
+ More Snippets
Document
PGR2017-00022, No. 2002 Exhibit - Expert Declaration of Dr William Wargin (P.T.A.B. Aug. 23, 2017)
Cite Document
PGR2017-00022, No. 2002 Exhibit - Expert Declaration of Dr William Wargin (P.T.A.B. Aug. 23, 2017)
+ More Snippets
Document
PGR2017-00022, No. 1045 Exhibit - Losina (P.T.A.B. May. 8, 2017)
Cite Document
PGR2017-00022, No. 1045 Exhibit - Losina (P.T.A.B. May. 8, 2017)
+ More Snippets
Document
PGR2017-00022, No. 2012 Exhibit - Harris, Effects of Risedronate Treatment on Vertebral and Nonvertebral Fractures in Women with Postmenopausal Osteoporosis, JAMA 1999 (P.T.A.B. Aug. ...
Cite Document
PGR2017-00022, No. 2012 Exhibit - Harris, Effects of Risedronate Treatment on Vertebral and Nonvertebral Fractures in Women with Postmenopausal Osteoporosis, JAMA 1999 (P.T.A.B. Aug. 23, 2017)
+ More Snippets
Document
PGR2017-00022, No. 2008 Exhibit - Conte, Safety of intravenous and oral bisphosphonates and compliance with dosing regimens, THE ONCOLOGIST 2004 (P.T.A.B. Aug. 23, 2017)
Cite Document
PGR2017-00022, No. 2008 Exhibit - Conte, Safety of intravenous and oral bisphosphonates and compliance with dosing regimens, THE ONCOLOGIST 2004 (P.T.A.B. Aug. 23, 2017)
+ More Snippets
Document
PGR2017-00022, No. 2011 Exhibit - Black, Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures, THE LANCET 1996 (P.T.A.B. Aug. 23, 2017)
Cite Document
PGR2017-00022, No. 2011 Exhibit - Black, Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures, THE LANCET 1996 (P.T.A.B. Aug. 23, 2017)
+ More Snippets